4th Quarter - Report

HELIX, INC. for HELIX, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 5, 2023 $40,000 Replaced
4th Quarter - Amendment Aug 3, 2023 $100,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Human and Viral Genomic research, testing,funding and insurance coverage, pandemic preparedness, viral surveillance, Lab Developed Tests H791 and S236 COVID-19 Variants Data Tracking (viral sequencing and analytic supports) H6584 Clinical Trial Diversity H 7667 Rx Drug and Device User Fee Programs (regulation of Lab Developed Tests) H 4128 VALID Act (regulation of Lab Developed Tests) H 2471 Omnibus (PREVENT Pandemics Act, funding for Advanced Molecular Detection, and VALID Act) S2022 Whole Genome Sequencing Clinic (Whole Exome sequencing)

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES —

Contacted: Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); White House Office; SENATE; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB)

Medical/Disease Research/Clinical Labs MED

viral and human genomic research, testing,funding and insurance coverage, COVID-19 testing and research, Lab Developed Tests H791 and S236 COVID-19 Variants Data Tracking (viral sequencing and analytic supports) H6584 Clinical Trial Diversity H 7667 Rx Drug and Device User Fee Programs (regulation of Lab Developed Tests) H 4128 VALID Act (regulation of Lab Developed Tests) H 2471 Omnibus (PREVENT Pandemics Act, funding for Advanced Molecular Detection, and VALID Act) S2022 Whole Genome Sequencing Clinic (Whole Exome sequencing)

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES New —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC)

Budget/Appropriations BUD

Covid Supplemental for surveillance and testing H2471 Omnibus (Funding for viral sequencing and surveillance, Advanced Molecular Detection, Public Health Infrastructure)

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Science/Technology SCI

Viral Surveillance, Viral and population genomics, Lab Developed Tests H 4128 VALID Act (Regulation of Lab Developed Tests)

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.